相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
Alessandro Mantovani et al.
GUT (2022)
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
Chandani Patel Chavez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
Fei Luo et al.
HEPATOLOGY COMMUNICATIONS (2022)
From NAFLD to MAFLD: Implications of a Premature Change in Terminology
Zobair M. Younossi et al.
HEPATOLOGY (2021)
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
Alessandro Mantovani et al.
GUT (2021)
Food as medicine: targeting the uraemic phenotype in chronic kidney disease
Denise Mafra et al.
NATURE REVIEWS NEPHROLOGY (2021)
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation
Adriana Marton et al.
NATURE REVIEWS NEPHROLOGY (2021)
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
Shang-Chin Huang et al.
GUT AND LIVER (2021)
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Clinical utility of the MAFLD definition
Kenneth I. Zheng et al.
JOURNAL OF HEPATOLOGY (2021)
Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling
Mingfeng Xia et al.
JOURNAL OF HEPATOLOGY (2021)
SGLT2 inhibitors may offer benefit beyond diabetes
Amy Kang et al.
NATURE REVIEWS NEPHROLOGY (2021)
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Radica Z. Alicic et al.
NATURE REVIEWS NEPHROLOGY (2021)
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
Yusuf Yilmaz et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Gabriel Tayguara Silveira Guerreiro et al.
HEPATOLOGY INTERNATIONAL (2021)
MAFLD and risk of CKD
Dan-Qin Sun et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo et al.
NATURE REVIEWS NEPHROLOGY (2021)
The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease
Dan-Qin Sun et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future
Ting-Yao Wang et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
Jonathan D. Ravid et al.
NATURE REVIEWS NEPHROLOGY (2021)
Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017-2018
Yunlei Deng et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)
Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene
Ze-Hua Zhao et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)
Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016
Hao-Jie Zhang et al.
CHINESE MEDICAL JOURNAL (2021)
Modeling PNPLA3-Associated NAFLD Using Human-Induced Pluripotent Stem Cells
Samantha G. Tilson et al.
HEPATOLOGY (2021)
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant
Helene Gellert-Kristensen et al.
HEPATOLOGY (2020)
Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease
Bo Kyung Koo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Fei Chen et al.
HEPATOLOGY (2020)
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD
D-Q Sun et al.
DIABETES & METABOLISM (2020)
PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels
Dan-Qin Sun et al.
LIVER INTERNATIONAL (2020)
NAD+ homeostasis in renal health and disease
Kenneth M. Ralto et al.
NATURE REVIEWS NEPHROLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings
Alessandro Mantovani et al.
LIVER INTERNATIONAL (2020)
Transmembrane 6 superfamily member 2 167K allele improves renal function in children with obesity
Pierluigi Marzuillo et al.
PEDIATRIC RESEARCH (2020)
The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease
Desh Raj et al.
PHARMACOLOGICAL RESEARCH (2020)
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Shiv K. Sarin et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
The case for evidence-based medicine for the association between hyperuricaemia and CKD
Stefanie Steiger et al.
NATURE REVIEWS NEPHROLOGY (2020)
Concordance between MAFLD and NAFLD diagnostic criteria in 'real-world' data
Giovanni Targher
LIVER INTERNATIONAL (2020)
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Su Lin et al.
LIVER INTERNATIONAL (2020)
Prevalence of NASH/NAFLD in people with obesity who are currently classified as metabolically healthy
Sebastien Frey et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2020)
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam et al.
HEPATOLOGY INTERNATIONAL (2020)
Letter regarding A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Lung-Yi Mak et al.
JOURNAL OF HEPATOLOGY (2020)
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura et al.
LIVER INTERNATIONAL (2020)
Pediatric non-alcoholic fatty liver disease and kidney function: Effect ofHSD17B13variant
Anna Di Sessa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease
Panu K. Luukkonen et al.
JCI INSIGHT (2020)
The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease
Edward S. Chambers et al.
DIABETES OBESITY & METABOLISM (2019)
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease
A. Mantovani et al.
DIABETES & METABOLISM (2019)
Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities
Kristina Onnerhag et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Yuka Sato et al.
NATURE REVIEWS NEPHROLOGY (2019)
Intestinal microbiome and fitness in kidney disease
Bjorn Meijers et al.
NATURE REVIEWS NEPHROLOGY (2019)
Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects
Lance A. Sloan
JOURNAL OF DIABETES (2019)
Nonalcoholic fatty liver disease and eGFR levels could be linked by the PNPLA3 I148M polymorphism in children with obesity
Pierluigi Marzuillo et al.
PEDIATRIC OBESITY (2019)
Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study
Keyang Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease
Siqi Wang et al.
CLINICAL SCIENCE (2019)
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children
Alessia Di Costanzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats
Laura G. Sanchez-Lozada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD
Anna Carter et al.
JOURNAL OF HEPATOLOGY (2019)
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease
James Paik et al.
LIVER INTERNATIONAL (2019)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
Tim Mitchell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Bile acid receptors and the kidney
Michal Herman-Edelstein et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis
Karn Wijarnpreecha et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
Eeva Sliz et al.
HUMAN MOLECULAR GENETICS (2018)
Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes
Ming-Wai Yeung et al.
JOURNAL OF HEPATOLOGY (2018)
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables
Umberto Vespasiani-Gentilucci et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells
Francesca Virginia Bruschi et al.
HEPATOLOGY (2017)
The Membrane-Bound O-Acyltransferase Domain-Containing 7 Variant rs641738 Increases Inflammation and Fibrosis in Chronic Hepatitis B
Khaled Thabet et al.
HEPATOLOGY (2017)
Emerging roles of SIRT1 in fatty liver diseases
Ren-Bo Ding et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
Xiaoxin X. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
Rosellina Margherita Mancina et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD
Giovanni Musso et al.
JOURNAL OF HEPATOLOGY (2016)
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Douglas J. Morrison et al.
GUT MICROBES (2016)
Insulin resistance in chronic kidney disease: a systematic review
Belinda Spoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Glomerular Diseases Associated With Hepatitis B and C
Anu Gupta et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
PNPLA3 rs738409 and TM6SF2 rs58542926 gene variants affect renal disease and function in nonalcoholic fatty liver disease
Giovanni Musso et al.
HEPATOLOGY (2015)
Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion
Vinicius Andrade-Oliveira et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Edward S. Chambers et al.
GUT (2015)
Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects
Kentaro Oniki et al.
PLOS ONE (2015)
Control of appetite and energy intake by SCFA: what are the potential underlying mechanisms?
Edward S. Chambers et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2015)
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2015)
CKD and Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
Valentina Giorgio et al.
DIGESTIVE AND LIVER DISEASE (2014)
Gut Bacterial Translocation May Aggravate Microinflammation in Hemodialysis Patients
Kehui Shi et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
Carlo Pirazzi et al.
HUMAN MOLECULAR GENETICS (2014)
GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study
Asahi Hishida et al.
JOURNAL OF NEPHROLOGY (2014)
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
Hellan K. Kwon et al.
LIVER INTERNATIONAL (2014)
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
Sanja Stojsavljevic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Metabolic syndrome and chronic kidney disease
Ajay K. Singh et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2013)
Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes
Kazuhiro Hasegawa et al.
NATURE MEDICINE (2013)
Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation
Jennifer L. Pluznick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro
Carlo Pirazzi et al.
JOURNAL OF HEPATOLOGY (2012)
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
Winston Dunn et al.
JOURNAL OF HEPATOLOGY (2012)
Prevalence, gender, ethnic variations, and prognosis of NASH
Etsuko Hashimoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
Carsten A. Boeger et al.
PLOS GENETICS (2011)
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
Mustafa S. Ascha et al.
HEPATOLOGY (2010)
Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis
Yusuf Yilmaz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
Smruti R. Mohanty et al.
JOURNAL OF HEPATOLOGY (2009)
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults
M Kurella et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The metabolic syndrome and chronic kidney disease in US adults
J Chen et al.
ANNALS OF INTERNAL MEDICINE (2004)
Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease
EM Brunt et al.
MODERN PATHOLOGY (2003)
分享论文
